| 缩写名/全名 |
BONE RES
Bone Research |
||||||||||||||||||||||||
| ISSN号 | 2095-4700 | ||||||||||||||||||||||||
| 研究方向 | CELL & TISSUE ENGINEERING- | ||||||||||||||||||||||||
| 影响因子 | 2015:3.549, 2016:9.326, 2017:12.354, 2018:, 2019:11.508, | ||||||||||||||||||||||||
| 出版国家 | PEOPLES R CHINA | ||||||||||||||||||||||||
| 出版周期 | |||||||||||||||||||||||||
| 年文章数 | 32 | ||||||||||||||||||||||||
| 出版年份 | 0 | ||||||||||||||||||||||||
| 是否OA | Yes | ||||||||||||||||||||||||
| 审稿周期(仅供参考) | |||||||||||||||||||||||||
| 录用比例 | |||||||||||||||||||||||||
| 投稿链接 | http://mts-boneres.nature.com/cgi-bin/main.plex | ||||||||||||||||||||||||
| 投稿官网 | http://www.nature.com/boneres/ | ||||||||||||||||||||||||
| h-index | 30 | ||||||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2095-4700%5BISSN%5D | ||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
| 中国学者近期发表的论文 | |
| 1. | Erratum: Author Correction: Exosomes-the enigmatic regulators of bone homeostasis. Author: Gao M1,2, Gao W3, Papadimitriou JM1,4, Zhang C5, Gao J1,2,5, Zheng M1,2. Journal: Bone Res. 2019 Jan 25;7:3. doi: 10.1038/s41413-018-0043-6. eCollection 2019. PubMed DOI |
| 2. | The potential risks of C-C chemokine receptor 5-edited babies in bone development. Author: Xie Y#1, Zhan S#2, Ge W2, Tang P1. Journal: Bone Res. 2019 Jan 29;7:4. doi: 10.1038/s41413-019-0044-0. eCollection 2019. PubMed DOI |
| 3. | Activation of mTORC1 in subchondral bone preosteoblasts promotes osteoarthritis by stimulating bone sclerosis and secretion of CXCL12. Author: Lin C#1,2, Liu L#1, Zeng C#1, Cui ZK3, Chen Y1, Lai P1,3, Wang H1, Shao Y1, Zhang H1, Zhang R1, Zhao C1, Fang H1, Cai D1, Bai X1,3. Journal: Bone Res. 2019 Feb 20;7:5. doi: 10.1038/s41413-018-0041-8. eCollection 2019. PubMed DOI |
| 4. | Collagen type II suppresses articular chondrocyte hypertrophy and osteoarthritis progression by promoting integrin β1-SMAD1 interaction. Author: Lian C#1,2, Wang X#2, Qiu X#2, Wu Z3, Gao B2, Liu L4, Liang G5, Zhou H1, Yang X1, Peng Y2, Liang A2, Xu C6, Huang D2, Su P1. Journal: Bone Res. 2019 Mar 6;7:8. doi: 10.1038/s41413-019-0046-y. eCollection 2019. PubMed DOI |
| 5. | Pathological mechanisms and therapeutic outlooks for arthrofibrosis. Author: Usher KM1, Zhu S2, Mavropalias G3, Carrino JA4, Zhao J5,6, Xu J1,5. Journal: Bone Res. 2019 Mar 26;7:9. doi: 10.1038/s41413-019-0047-x. eCollection 2019. PubMed DOI |
| 6. | Connexin 43 hemichannels protect bone loss during estrogen deficiency. Author: Ma L#1,2, Hua R#2, Tian Y2, Cheng H2, Fajardo RJ3, Pearson JJ4, Guda T4, Shropshire DB2, Gu S2, Jiang JX2. Journal: Bone Res. 2019 Apr 22;7:11. doi: 10.1038/s41413-019-0050-2. eCollection 2019. PubMed DOI |
| 7. | Correction to: Suppressive effects of plumbagin on invasion and migration of breast cancer cells via the inhibition of STAT3 signaling and down-regulation of inflammatory cytokine expressions. Author: Yan W1,2, Tu B1, Liu YY3, Wang TY4, Qiao H1, Zhai ZJ1, Li HW1, Tang TT1. Journal: Bone Res. 2019 May 22;7:16. doi: 10.1038/s41413-019-0052-0. eCollection 2019. PubMed DOI |
| 8. | Crosstalk between adipose-derived stem cells and chondrocytes: when growth factors matter. Author: Zhong J, Guo B, Xie J, Deng S, Fu N, Lin S, Li G, Lin Y, Cai X. Journal: Bone Res. 2016 Feb 3;4:15036. doi: 10.1038/boneres.2015.36. eCollection 2016. PubMed |
| 9. | Current research on pharmacologic and regenerative therapies for osteoarthritis. Author: Zhang W, Ouyang H, Dass CR, Xu J. Journal: Bone Res. 2016 Mar 1;4:15040. doi: 10.1038/boneres.2015.40. eCollection 2016. Review. PubMed |
| 10. | The biological function of type I receptors of bone morphogenetic protein in bone. Author: Lin S, Svoboda KK, Feng JQ, Jiang X. Journal: Bone Res. 2016 Apr 5;4:16005. doi: 10.1038/boneres.2016.5. eCollection 2016. Review. PubMed |
|
| ||||||||||
